Patients with Advanced Pancreatic Cancer and Hyperbilirubinaemia: Review and German Expert Opinion on Treatment with nab-Paclitaxel plus Gemcitabine (vol 38, pg 596, 2015)

被引:0
|
作者
Vogel, Arndt [1 ]
Kullmann, Frank [2 ]
Kunzmann, Volker [3 ]
Al-Batrand, Salah-Eddin [4 ]
Oettle, Helmut [5 ]
Plentz, Ruben [6 ]
Siveke, Jens [7 ]
Springfeld, Christoph [8 ]
Riess, Hanno [9 ]
机构
[1] Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, Hannover, Germany
[2] Klinikum Weiden, Med Klin 1, Weiden, Germany
[3] Univ Klinikum, Med Klin & Poliklin 2, Schwerpunkt Med Onkol, Wurzburg, Germany
[4] Univ Canc Ctr, Krankenhaus Nordwest, Frankfurt, Germany
[5] Onkol Schwerpunktpraxis, Friedrichshafen, Germany
[6] Univ Clin Tubingen, Tubingen, Germany
[7] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 2, D-80290 Munich, Germany
[8] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany
[9] Charite, Med Klin Schwerpunkt Hamatol Onkol & Tumorimmunol, Berlin, Germany
关键词
D O I
10.1159/000442191
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:691 / 691
页数:1
相关论文
共 50 条
  • [11] Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer
    Tsujimoto, Akiko
    Sudo, Kentaro
    Nakamura, Kazuyoshi
    Kita, Emiri
    Hara, Ryusuke
    Takayama, Wataru
    Ishii, Hiroshi
    Yamaguchi, Taketo
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [12] Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer
    Borazanci, Erkut
    Von Hoff, Daniel D.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) : 739 - 747
  • [13] Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer
    Akiko Tsujimoto
    Kentaro Sudo
    Kazuyoshi Nakamura
    Emiri Kita
    Ryusuke Hara
    Wataru Takayama
    Hiroshi Ishii
    Taketo Yamaguchi
    Scientific Reports, 9
  • [14] Safety and efficacy of Nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering from cholestatic hyperbilirubinaemia-A retrospective analysis
    Pelzer, Uwe
    Wislocka, Lilianna
    Juehling, Anja
    Striefler, Jana
    Klein, Fritz
    Roemmler-Zehrer, Josefine
    Sinn, Marianne
    Denecke, Tim
    Bahra, Marcus
    Riess, Hanno
    EUROPEAN JOURNAL OF CANCER, 2018, 100 : 85 - 93
  • [15] Treatment outcomes of gemcitabine plus nab-paclitaxel in pancreatic cancer patients with malignant ascites
    Inoue, Kanae
    Fukushi, Koh
    Yamaguchi, Shota
    Taira, Tomonao
    Shibuki, Taro
    Satake, Tomoyuki
    Watanabe, Kazuo
    Sasaki, Mitsuhito
    Imaoka, Hiroshi
    Mitsunaga, Shuichi
    Ikeda, Masafumi
    PANCREATOLOGY, 2024, 24 (04) : 616 - 623
  • [16] A Multicenter Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Elderly Patients With Advanced Pancreatic Cancer
    Kobayashi, Satoshi
    Ueno, Makoto
    Ikeda, Masafumi
    Ozaka, Masato
    Sano, Yusuke
    Hirotani, Akane
    Tozuka, Yuichiro
    Fukushima, Taito
    Tezuka, Shun
    Moriya, Satoshi
    Umemoto, Kumiko
    Watanabe, Kazuo
    Sasaki, Mitsuhito
    Hashimoto, Yusuke
    Imaoka, Hiroshi
    Ohno, Izumi
    Mitsunaga, Shuichi
    Yamada, Ikuhiro
    Sasaki, Takashi
    Sasahira, Naoki
    Morimoto, Manabu
    PANCREAS, 2020, 49 (02) : 187 - 192
  • [17] Safety and efficacy of gemcitabine plus nab-paclitaxel therapy in elderly patients with advanced pancreatic cancer
    Aoki, Yu
    Sukawa, Yasutaka
    Kawasaki, Kenta
    Suzuki, Takeshi
    Hirata, Kenro
    Kasuga, Akiyoshi
    Iwasaki, Eisuke
    Hamamoto, Yasuo
    Takaishi, Hiromasa
    Kanai, Takanori
    ANNALS OF ONCOLOGY, 2017, 28
  • [18] Gemcitabine plus nab-paclitaxel with initial dose reduction for older patients with advanced pancreatic cancer
    Ibusuki, Mayu
    Inoue, Tadahisa
    Kitano, Rena
    Sakamoto, Kazumasa
    Kimoto, Satoshi
    Kobayashi, Yuji
    Ohashi, Tomohiko
    Sumida, Yoshio
    Nakade, Yukiomi
    Ito, Kiyoaki
    Yoneda, Masashi
    JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (01) : 118 - 121
  • [19] Multicenter retrospective study of gemcitabine plus nab-paclitaxel for elderly patients with advanced pancreatic cancer
    Ozaka, M.
    Kobayashi, S.
    Ikeda, M.
    Ueno, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 270 - 270
  • [20] Prognostic impact of osteosarcopenia in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel
    Takeda, Tsuyoshi
    Sasaki, Takashi
    Okamoto, Takeshi
    Ishitsuka, Takahiro
    Yamada, Manabu
    Nakagawa, Hiroki
    Mie, Takafumi
    Furukawa, Takaaki
    Kasuga, Akiyoshi
    Matsuyama, Masato
    Ozaka, Masato
    Sasahira, Naoki
    PANCREATOLOGY, 2023, 23 (03) : 275 - 282